Aldose reductase regulates acrolein-induced cytotoxicity in human small airway epithelial cells

Umesh C S Yadav, Kota Ramana, Satish Srivastava

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Aldose reductase (AR), a glucose-metabolizing enzyme, reduces lipid aldehydes and their glutathione conjugates with more than 1000-fold efficiency (Km aldehydes 5-30 μM) relative to glucose. Acrolein, a major endogenous lipid peroxidation product as well as a component of environmental pollutants and cigarette smoke, is known to be involved in various pathologies including atherosclerosis, airway inflammation, COPD, and age-related disorders, but the mechanism of acrolein-induced cytotoxicity is not clearly understood. We have investigated the role of AR in acrolein-induced cytotoxicity in primary human small airway epithelial cells (SAECs). Exposure of SAECs to varying concentrations of acrolein caused cell death in a concentration- and time-dependent manner. AR inhibition by fidarestat prevented the low-dose (5-10 μM) but not the high-dose (>10 μM) acrolein-induced SAEC death. AR inhibition protected SAECs from low-dose (5 μM) acrolein-induced cellular reactive oxygen species (ROS). Inhibition of acrolein-induced apoptosis by fidarestat was confirmed by decreased condensation of nuclear chromatin, DNA fragmentation, comet tail moment, and annexin V fluorescence. Further, fidarestat inhibited acrolein-induced translocation of the proapoptotic proteins Bax and Bad from the cytosol to the mitochondria and that of Bcl2 and Bcl XL from the mitochondria to the cytosol. Acrolein-induced cytochrome c release from mitochondria was also prevented by AR inhibition. The mitogen-activated protein kinases (MAPKs), such as extracellular signal-regulated kinases 1 and 2, stress-activated protein kinase/c-Jun NH 2-terminal kinase, and p38MAPK, and c-Jun were transiently activated in airway epithelial cells by acrolein in a concentration- and time-dependent fashion, which was significantly prevented by AR inhibition. These results suggest that AR inhibitors could prevent acrolein-induced cytotoxicity in the lung epithelial cells.

Original languageEnglish (US)
Pages (from-to)15-25
Number of pages11
JournalFree Radical Biology and Medicine
Volume65
DOIs
StatePublished - 2013

Fingerprint

Acrolein
Aldehyde Reductase
Cytotoxicity
Epithelial Cells
Mitochondria
Cell death
Aldehydes
Cytosol
bcl-Associated Death Protein
Cell Death
Lipids
Glucose
bcl-2-Associated X Protein
Environmental Pollutants
Mitogen-Activated Protein Kinase 3
Annexin A5
Mitogen-Activated Protein Kinase 1
Pathology
DNA Fragmentation
Protein Transport

Keywords

  • Acrolein
  • Airway epithelial cells
  • Aldose reductase
  • Apoptosis
  • COPD
  • Cytotoxicity
  • Free radicals

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Aldose reductase regulates acrolein-induced cytotoxicity in human small airway epithelial cells. / Yadav, Umesh C S; Ramana, Kota; Srivastava, Satish.

In: Free Radical Biology and Medicine, Vol. 65, 2013, p. 15-25.

Research output: Contribution to journalArticle

@article{06ad8e13af204b75b6a77393e6cbc34e,
title = "Aldose reductase regulates acrolein-induced cytotoxicity in human small airway epithelial cells",
abstract = "Aldose reductase (AR), a glucose-metabolizing enzyme, reduces lipid aldehydes and their glutathione conjugates with more than 1000-fold efficiency (Km aldehydes 5-30 μM) relative to glucose. Acrolein, a major endogenous lipid peroxidation product as well as a component of environmental pollutants and cigarette smoke, is known to be involved in various pathologies including atherosclerosis, airway inflammation, COPD, and age-related disorders, but the mechanism of acrolein-induced cytotoxicity is not clearly understood. We have investigated the role of AR in acrolein-induced cytotoxicity in primary human small airway epithelial cells (SAECs). Exposure of SAECs to varying concentrations of acrolein caused cell death in a concentration- and time-dependent manner. AR inhibition by fidarestat prevented the low-dose (5-10 μM) but not the high-dose (>10 μM) acrolein-induced SAEC death. AR inhibition protected SAECs from low-dose (5 μM) acrolein-induced cellular reactive oxygen species (ROS). Inhibition of acrolein-induced apoptosis by fidarestat was confirmed by decreased condensation of nuclear chromatin, DNA fragmentation, comet tail moment, and annexin V fluorescence. Further, fidarestat inhibited acrolein-induced translocation of the proapoptotic proteins Bax and Bad from the cytosol to the mitochondria and that of Bcl2 and Bcl XL from the mitochondria to the cytosol. Acrolein-induced cytochrome c release from mitochondria was also prevented by AR inhibition. The mitogen-activated protein kinases (MAPKs), such as extracellular signal-regulated kinases 1 and 2, stress-activated protein kinase/c-Jun NH 2-terminal kinase, and p38MAPK, and c-Jun were transiently activated in airway epithelial cells by acrolein in a concentration- and time-dependent fashion, which was significantly prevented by AR inhibition. These results suggest that AR inhibitors could prevent acrolein-induced cytotoxicity in the lung epithelial cells.",
keywords = "Acrolein, Airway epithelial cells, Aldose reductase, Apoptosis, COPD, Cytotoxicity, Free radicals",
author = "Yadav, {Umesh C S} and Kota Ramana and Satish Srivastava",
year = "2013",
doi = "10.1016/j.freeradbiomed.2013.06.008",
language = "English (US)",
volume = "65",
pages = "15--25",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Aldose reductase regulates acrolein-induced cytotoxicity in human small airway epithelial cells

AU - Yadav, Umesh C S

AU - Ramana, Kota

AU - Srivastava, Satish

PY - 2013

Y1 - 2013

N2 - Aldose reductase (AR), a glucose-metabolizing enzyme, reduces lipid aldehydes and their glutathione conjugates with more than 1000-fold efficiency (Km aldehydes 5-30 μM) relative to glucose. Acrolein, a major endogenous lipid peroxidation product as well as a component of environmental pollutants and cigarette smoke, is known to be involved in various pathologies including atherosclerosis, airway inflammation, COPD, and age-related disorders, but the mechanism of acrolein-induced cytotoxicity is not clearly understood. We have investigated the role of AR in acrolein-induced cytotoxicity in primary human small airway epithelial cells (SAECs). Exposure of SAECs to varying concentrations of acrolein caused cell death in a concentration- and time-dependent manner. AR inhibition by fidarestat prevented the low-dose (5-10 μM) but not the high-dose (>10 μM) acrolein-induced SAEC death. AR inhibition protected SAECs from low-dose (5 μM) acrolein-induced cellular reactive oxygen species (ROS). Inhibition of acrolein-induced apoptosis by fidarestat was confirmed by decreased condensation of nuclear chromatin, DNA fragmentation, comet tail moment, and annexin V fluorescence. Further, fidarestat inhibited acrolein-induced translocation of the proapoptotic proteins Bax and Bad from the cytosol to the mitochondria and that of Bcl2 and Bcl XL from the mitochondria to the cytosol. Acrolein-induced cytochrome c release from mitochondria was also prevented by AR inhibition. The mitogen-activated protein kinases (MAPKs), such as extracellular signal-regulated kinases 1 and 2, stress-activated protein kinase/c-Jun NH 2-terminal kinase, and p38MAPK, and c-Jun were transiently activated in airway epithelial cells by acrolein in a concentration- and time-dependent fashion, which was significantly prevented by AR inhibition. These results suggest that AR inhibitors could prevent acrolein-induced cytotoxicity in the lung epithelial cells.

AB - Aldose reductase (AR), a glucose-metabolizing enzyme, reduces lipid aldehydes and their glutathione conjugates with more than 1000-fold efficiency (Km aldehydes 5-30 μM) relative to glucose. Acrolein, a major endogenous lipid peroxidation product as well as a component of environmental pollutants and cigarette smoke, is known to be involved in various pathologies including atherosclerosis, airway inflammation, COPD, and age-related disorders, but the mechanism of acrolein-induced cytotoxicity is not clearly understood. We have investigated the role of AR in acrolein-induced cytotoxicity in primary human small airway epithelial cells (SAECs). Exposure of SAECs to varying concentrations of acrolein caused cell death in a concentration- and time-dependent manner. AR inhibition by fidarestat prevented the low-dose (5-10 μM) but not the high-dose (>10 μM) acrolein-induced SAEC death. AR inhibition protected SAECs from low-dose (5 μM) acrolein-induced cellular reactive oxygen species (ROS). Inhibition of acrolein-induced apoptosis by fidarestat was confirmed by decreased condensation of nuclear chromatin, DNA fragmentation, comet tail moment, and annexin V fluorescence. Further, fidarestat inhibited acrolein-induced translocation of the proapoptotic proteins Bax and Bad from the cytosol to the mitochondria and that of Bcl2 and Bcl XL from the mitochondria to the cytosol. Acrolein-induced cytochrome c release from mitochondria was also prevented by AR inhibition. The mitogen-activated protein kinases (MAPKs), such as extracellular signal-regulated kinases 1 and 2, stress-activated protein kinase/c-Jun NH 2-terminal kinase, and p38MAPK, and c-Jun were transiently activated in airway epithelial cells by acrolein in a concentration- and time-dependent fashion, which was significantly prevented by AR inhibition. These results suggest that AR inhibitors could prevent acrolein-induced cytotoxicity in the lung epithelial cells.

KW - Acrolein

KW - Airway epithelial cells

KW - Aldose reductase

KW - Apoptosis

KW - COPD

KW - Cytotoxicity

KW - Free radicals

UR - http://www.scopus.com/inward/record.url?scp=84884574846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884574846&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2013.06.008

DO - 10.1016/j.freeradbiomed.2013.06.008

M3 - Article

VL - 65

SP - 15

EP - 25

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

ER -